Numiaris MedTech

Medical device consulting

From concept to market.

Research and development, regulatory strategy, technology transfer and manufacturing. We support medical device manufacturers from early development through market launch and post-market follow-up.

Discuss your project

Device studiesConcept sketches

Strategic and technical advisory

Where we can help

A start-up with a prototype, a manufacturer facing a process failure and an investor reviewing a technology each have a different decision to make.

Strategy and business development

Assess the clinical need, the market and the technology risks before committing to development, a partnership or an investment.

Device development

Turn the clinical need into design inputs. Compare materials and prototypes, then select the tests that will guide the next decision.

Technical troubleshooting

Reproduce the failure, identify its cause and verify the corrective action on the device or manufacturing process.

Quality and regulatory affairs

Connect design records, risk management and clinical evidence to the technical documentation and post-market follow-up.

A gloved hand examining an implant concept alongside its engineering drawing.
Design review of a device concept.

We define the decision, diagnose the problem, agree on a plan and review the results with your team.

Device development

Eight development milestones

Regulatory strategy, risk management and manufacturing planning start when the intended use is defined and continue through post-market monitoring.

  1. Research and clinical need

    Define intended use, users, the state of the art and target countries. Establish the product profile and development roadmap.

  2. Feasibility and prototyping

    Compare concepts and test critical materials or design features. Use the prototype to establish proof of concept.

  3. Design and development

    Translate needs into design inputs. Document the specifications, design decisions and associated risks.

  4. Verification, validation and clinical evidence

    Link each requirement to its verification test and the intended use to validation and clinical evidence.

  5. Transfer to manufacturing

    Prepare the receiving site, qualify equipment and assess process control on pilot batches. Define release criteria.

  6. Conformity and CE marking

    Consolidate the technical documentation and prepare the applicable conformity assessment with the manufacturer.

  7. Launch and market access

    Plan the launch country by country. Assess distribution channels and the evidence needed for reimbursement.

  8. Routine production and surveillance

    Monitor performance, complaints and vigilance reports. Use field findings to guide design and process changes.

Materials and surface R&D

Surfaces and new alloys

A stent deforms as it opens. A dental connection bears load each time it is assembled. Those conditions guide the choice of alloy, surface and tests.

Select the alloy

Compare composition and microstructure, then assess fatigue and corrosion under conditions relevant to the device.

Engineer the surface

Select a microtexture, plasma activation or a physical vapour deposition (PVD) coating according to the intended surface function.

Qualify the process

Use microscopy, profilometry and adhesion tests to turn surface properties into acceptance criteria, from test coupons to pilot batches.

Coated metal test coupons beside the opening of a PVD chamber.
Coated test coupons and a PVD chamber. Concept illustration.

Nitinol for a self-expanding stent and titanium alloys for a dental connection illustrate two different sets of material requirements.

Patents and publications

Research in surface engineering

Selected work by Dr Mustapha Mekki on implant coatings, physical vapour deposition and drug loading in coronary stents.

Radiopaque tantalum adhesion layer · EP 4 065 186

WO 2021/105403 A1 names Johannes Lammer and Mustapha Mekki as inventors and IMC International Medical Contrivances SA as applicant.

Coloured metal coatings · WO 2009/004163 A1

This application describes physical deposition of a metal or alloy to produce a coloured surface. It names Mustapha Mekki as inventor and applicant.

Filling the reservoirs of a stent

Dr Mustapha Mekki, founder of Numiaris MedTech, is the first author of this 2009 study on filling stent microreservoirs with L-arginine and coating them with polyethylene glycol (PEG) and dexamethasone.

Mekki M, Durual S, Scherrer SS, Lammers J, Wiskott HWA. Optimization of Plasma Treatment, Manipulative Variables and Coating Composition for the Controlled Filling and Coating of a Microstructured Reservoir Stent. Journal of Medical Devices, 2009, 3(1), 011005. DOI 10.1115/1.3081394.

Illustration of the interface between a metallic surface and biological tissue.
A material in contact with cells and bacteria. Concept illustration of a biointerface.

Coronary stents

Microreservoirs in the struts

The full stent view places the reservoirs within the lattice. Each blind cavity opens onto the outer face of a straight strut.

Localised microstructuring

The cavity floor retains a continuous layer of metal. The rows end before the curved crowns, and the links have a smooth surface.

Direct drug loading

The concept uses the cavities to hold sirolimus directly in the metal struts, without a polymer carrier.

Pencil drawing of the full cylindrical stent. Rows of small cavities follow the straight sections of its lattice.
Concept drawing of a coronary stent, not to scale.
View the stent struts in detail
Oblique view of a cylindrical stent with a ring-shaped opening at either end.
Entire coronary stent.
A series of round recesses lies on the outward-facing side of the straight metal strut.
Concept rendering of a straight strut at higher magnification. The metal floor is visible in each recess.

Inside a straight strut

Cross-section showing a shallow recess with an unbroken metal floor.
Empty reservoir · Continuous metal floor.
The same metal cross-section with sirolimus shown schematically inside the recess.
Same reservoir after loading · Sirolimus.

Depth shown schematically.

Grayscale view of the interconnected metal struts of the stent.
Scanning electron micrograph of coronary stent struts. The rows of microreservoirs stop before the crowns, which remain smooth. Scale bar: 1 mm.

Quality, clinical and regulatory affairs

Preparing for CE marking

For a class III implant, design records, manufacturing evidence and the clinical evaluation are developed together. We help the manufacturer assemble that evidence.

European regulatory strategy

Define the intended purpose, justify the risk class and prepare the applicable conformity assessment under the EU MDR.

Quality systems and risk

Link the ISO 13485 quality system and ISO 14971 risk management to design decisions, testing and manufacturing changes.

Clinical evidence and GxP

Plan the clinical evaluation and applicable investigations under ISO 14155. Identify GLP requirements for relevant non-clinical safety studies.

Technical documentation and follow-up

Connect the documentation required by Annexes II and III to post-market surveillance, clinical follow-up and vigilance.

A detail from a design drawing for an implant.
Design documentation. Concept illustration.

For a series-produced class III device, the notified body assesses conformity. The manufacturer draws up the EU declaration of conformity and affixes the CE marking.

Manufacturing and technology transfer

From the lab to production

Whether the project involves a new manufacturing site or an existing line, we define the transfer with the team that will produce and release the device.

Plan the receiving site

Define capacity, flows of materials and personnel, utilities, workstations and any controlled areas or cleanrooms the device requires.

Transfer the complete process

Transfer drawings, tooling, work instructions and inspection methods. Select suppliers and train the receiving team.

Qualify and scale up

Qualify equipment, validate applicable processes and run pilot batches. Establish packaging, sterilisation where needed and release criteria.

A cleanroom aisle and the assembly equipment of a pilot production area.
Pilot assembly area for medical devices. Concept illustration.

The transfer package records responsibilities, estimated costs, pilot batches and line acceptance criteria.

Device families

Medical devices and implants

From delivery systems to dental connections, the interfaces between components shape the design and the tests each device needs.

Concept illustrations

Covered stents and stent grafts

Straight covered stents and bifurcated aortic grafts.

Coronary stents

Stent lattice, crimping and balloon deployment.

Peripheral stents

Self-expanding nitinol frame and delivery sheath.

Catheters, balloons and valves

Delivery catheter, angioplasty balloon and valve frame.

Dental implants and connections

Implant body, connector, fixation screw and restoration.

Prosthetic components

Transmucosal abutment and the seating of a ceramic restoration.

Technical guide

The language of device development

The terms below appear in project briefs, test plans, transfer packages and regulatory submissions.

Design and feasibility

Intended purpose, state of the art, proof of concept, computer-aided design (CAD), design inputs and design for manufacture (DFM).

Performance and clinical evidence

Verification and validation (V&V), bench testing, usability, biological evaluation, clinical evaluation and clinical investigations.

Quality and risk

Quality management system (QMS), ISO 13485, risk management (ISO 14971), change control and corrective and preventive action (CAPA).

Manufacturing and transfer

Equipment and process qualification (IQ/OQ/PQ), pilot lots, process validation, packaging, sterilisation where applicable, and release.

Access to market

EU MDR, CE marking, unique device identification (UDI), pricing, procurement and reimbursement by country.

Post-market follow-up

Post-market surveillance (PMS), post-market clinical follow-up (PMCF), vigilance and periodic safety update reports (PSUR), where applicable.

Business development

Partnerships and market access

A manufacturer bringing production in-house and an investor assessing a device need different evidence. We build the case around the decision they face.

Market entry and reimbursement

Identify who prescribes, buys and pays. Test pricing and reimbursement assumptions to build a launch plan for each market.

Industrial partnerships

Compare local manufacture, OEM supply, licensing and distribution. Define the partner’s capabilities, investment, technology rights and quality responsibilities.

Due diligence and funding

Assess device maturity, evidence gaps and industrial risks. Link funding needs to the next technical and commercial milestones.

A complete technology transfer

Cost the equipment, tooling, training and pilot lots. Agree with the receiving team how it will demonstrate the line meets acceptance criteria.

From Geneva, we work with teams in Switzerland and abroad. We agree on access to project information and on which deliverables can be shared.

Contact

Discuss your project

For a medical device development programme, regulatory strategy or manufacturing transfer, contact Dr Mustapha Mekki in Geneva.

Your contact

Dr Mustapha Mekki

Managing Partner

contact@numiaris.ch

Registered office

Numiaris MedTech Sàrl

c/o ExpertFid & Audit SA
Cours des Bastions 13
1205 Geneva, Switzerland

Swiss enterprise ID CHE-208.158.574